H

HaTay Pharmaceutical JSC
VN:DHT

Watchlist Manager
HaTay Pharmaceutical JSC
VN:DHT
Watchlist
Price: 95 700 VND 0.84% Market Closed
Market Cap: 7.9T VND
Have any thoughts about
HaTay Pharmaceutical JSC?
Write Note

HaTay Pharmaceutical JSC
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

HaTay Pharmaceutical JSC
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
H
HaTay Pharmaceutical JSC
VN:DHT
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
Imexpharm Corp
VN:IMP
Note Receivable
â‚«2.3B
CAGR 3-Years
81%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
C
Cuu Long Pharmaceutical JSC
VN:DCL
Note Receivable
â‚«3.5B
CAGR 3-Years
111%
CAGR 5-Years
345%
CAGR 10-Years
N/A
D
Domesco Medical Import Export Joint Stock Corp
VN:DMC
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Note Receivable
â‚«695.1m
CAGR 3-Years
3%
CAGR 5-Years
8%
CAGR 10-Years
N/A
T
Traphaco JSC
VN:TRA
Note Receivable
â‚«0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

HaTay Pharmaceutical JSC
Glance View

Market Cap
7.9T VND
Industry
Pharmaceuticals

Ha Tay Pharmaceutical JSC engages in the manufacture, import and export of drugs, medicine, cosmetic and medical equipment. The company is headquartered in Hanoi, Hanoi. The company went IPO on 2008-12-03. The company is engaged in the manufacturing, marketing, wholesale and retail trading, import and export of pharmaceutical products, preparations and materials, vaccines, along with medical equipment and supplies. The firm also manufactures and trades cosmetic products, supplemental food, general chemicals and specialized chemicals for laboratory tests. Other activities include supermarket operations, office and apartment leasing, real estate brokerage services, as well as the provision of vocational training services. The firm announced that it has completed the acquisition of 50.626% stake in Ha Tay Pharmaceutical and Medical Equipments Joint Stock Company by the end of the third quarter of 2013.

DHT Intrinsic Value
18 592.65 VND
Overvaluation 81%
Intrinsic Value
Price
H

See Also

Back to Top